Menu Search
Equities

Scworx Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4R80:FRA

Scworx Corp

Actions
  • Price (EUR)1.26
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change+5.00%
  • Beta2.1504
Data delayed at least 15 minutes, as of Feb 24 2025 07:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

SCWorx Corp. is a provider of data content and services related to the repair, normalization and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. The Company has developed and markets health care information technology solutions and associated services that enhance healthcare processes and information flow within hospitals and other healthcare facilities. Its software enables a healthcare provider to simplify and organize its data (data normalization), allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics (big data). Its software modules include virtualized item master file repair, expansion and automation, electronic medical record management, charge description master management, contract management, request for proposal (RFP) automation, integration of acquired businesses, rebate management, and data integration and warehousing.

  • Revenue in USD (TTM)2.78m
  • Net income in USD-3.89m
  • Incorporated2015
  • Employees7.00
  • Location
    Scworx Corp35 VILLAGE RD, SUITE 100MIDDLETON 01949United StatesUSA
  • Phone+1 (212) 739-7825
  • Fax+1 (302) 655-5049
  • Websitehttps://www.scworx.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.